10.20Open10.20Pre Close0 Volume1 Open Interest155.00Strike Price0.00Turnover823.22%IV116.20%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry10.20Extrinsic Value100Contract SizeAmericanOptions Type0.3467Delta0.0056Gamma7.49Leverage Ratio-3.1422Theta0.0018Rho2.60Eff Leverage0.0294Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet